Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
GSK plc | 10%+ Owner | $134M | +$22.3M | +20% | Sep 27, 2024 |
Ken Takanashi | Director, 10%+ Owner | $14.2M | Aug 12, 2024 | ||
Paul Bolno | President and CEO, Director | $839K | -$3.12M | -78.8% | Feb 4, 2025 |
Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | $672K | Feb 4, 2025 | ||
Kyle Moran | Chief Financial Officer | $221K | -$251K | -53.1% | Feb 4, 2025 |
Gregory L. Verdine | Director | $114K | Aug 12, 2024 | ||
Heidi Wagner | Director | $79.9K | Aug 12, 2024 | ||
Mark Corrigan | Director | $79.9K | Aug 12, 2024 | ||
Chris Francis | SVP, Corporate Development, Head of Emerging Areas | $62K | -$3.43M | -98.2% | Feb 4, 2025 |
Ra Capital Management, L.P. | Director, 10%+ Owner | $40K | Aug 12, 2024 | ||
Christian O. Henry | Director | $40K | Aug 12, 2024 | ||
Adrian Rawcliffe | Director | $40K | Aug 12, 2024 | ||
Aik Na Tan | Director | $40K | Aug 12, 2024 | ||
Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | Jul 25, 2022 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|